BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

13959 related articles for article (PubMed ID: 10489624)

  • 1. Skin precancer.
    Brash DE; Pontén J
    Cancer Surv; 1998; 32():69-113. PubMed ID: 10489624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of the transcription factor p53 in keratinocyte carcinomas.
    Brash DE
    Br J Dermatol; 2006 May; 154 Suppl 1():8-10. PubMed ID: 16712710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis.
    Kubo Y; Urano Y; Yoshimoto K; Iwahana H; Fukuhara K; Arase S; Itakura M
    J Invest Dermatol; 1994 Apr; 102(4):440-4. PubMed ID: 8151121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer.
    Rass K; Reichrath J
    Adv Exp Med Biol; 2008; 624():162-78. PubMed ID: 18348455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
    Reichrath J; Rass K
    Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin.
    Ren ZP; Ahmadian A; Pontén F; Nistér M; Berg C; Lundeberg J; Uhlén M; Pontén J
    Am J Pathol; 1997 May; 150(5):1791-803. PubMed ID: 9137102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
    Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
    Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
    Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The density of epidermal p53 clones is higher adjacent to squamous cell carcinoma in comparison with basal cell carcinoma.
    Bäckvall H; Wolf O; Hermelin H; Weitzberg E; Pontén F
    Br J Dermatol; 2004 Feb; 150(2):259-66. PubMed ID: 14996096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultraviolet B-induced squamous epithelial and melanocytic cell changes in a xenograft model of cancer development in human skin.
    Sauter ER; Klein-Szanto AJ; Atillasoy E; Montone KT; Goodrow T; Binder RL; Seykora JT; Herlyn M
    Mol Carcinog; 1998 Nov; 23(3):168-74. PubMed ID: 9833777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-melanoma skin cancer in mouse and man.
    Schwarz M; Münzel PA; Braeuning A
    Arch Toxicol; 2013 May; 87(5):783-98. PubMed ID: 23266722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma progression.
    Elder DE
    Pathology; 2016 Feb; 48(2):147-54. PubMed ID: 27020387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclonal Evolution of Cancer-Related Gene Mutations in p53 Immunopositive Patches in Human Skin.
    Albibas AA; Rose-Zerilli MJJ; Lai C; Pengelly RJ; Lockett GA; Theaker J; Ennis S; Holloway JW; Healy E
    J Invest Dermatol; 2018 Jan; 138(1):189-198. PubMed ID: 28844940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of TP53 and MDM2 polymorphisms in TP53 mutagenesis and risk of non-melanoma skin cancer.
    Almquist LM; Karagas MR; Christensen BC; Welsh MM; Perry AE; Storm CA; Nelson HH
    Carcinogenesis; 2011 Mar; 32(3):327-30. PubMed ID: 21123835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis.
    Ren ZP; Pontén F; Nistér M; Pontén J
    Int J Cancer; 1996 Jun; 69(3):174-9. PubMed ID: 8682583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
    Reifenberger J; Wolter M; Knobbe CB; Köhler B; Schönicke A; Scharwächter C; Kumar K; Blaschke B; Ruzicka T; Reifenberger G
    Br J Dermatol; 2005 Jan; 152(1):43-51. PubMed ID: 15656799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 mutations in human skin cancers.
    Giglia-Mari G; Sarasin A
    Hum Mutat; 2003 Mar; 21(3):217-28. PubMed ID: 12619107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
    Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN
    Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin Cancer: Precancers.
    Bruner P; Bashline B
    FP Essent; 2019 Jun; 481():23-27. PubMed ID: 31188549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion.
    Brash DE; Ziegler A; Jonason AS; Simon JA; Kunala S; Leffell DJ
    J Investig Dermatol Symp Proc; 1996 Apr; 1(2):136-42. PubMed ID: 9627707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 698.